Rheumatoid Arthritis Terminated Phase 3 Trials for Tabalumab (DB11657)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01215942An Open Label Study for Participants With Rheumatoid ArthritisTreatment
NCT01202773A Study in Participants With Rheumatoid ArthritisTreatment
NCT01198002A Rheumatoid Arthritis Study in Participants on a Background Treatment of MethotrexateTreatment
NCT01676701Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)Treatment